GUFIC BIOSCIENCES LTD. - 509079 - Announcement under Regulation 30 (LODR)-Investor Presentation
Investor Presentation on Unaudited Financial Results of the Company for the quarter and nine months ended December 31, 2023 is attached herewith. GUFIC BIOSCIENCES LTD. - 509079 - Statement Of Deviation(S) Or Variation(S) In The Use Of Proceeds Of Preferential Issue Of Equity Shares For The Quarter Ended December 31, 2023
Statement of deviation(s) or variation(s) in the use of proceeds of Preferential Issue of Equity Shares for the quarter ended December 31, 2023 is attached herewith GUFIC BIOSCIENCES LTD. - 509079 - Unaudited Financial Results (Standalone And Consolidated) For The Quarter And Nine Months Ended December 31, 2023
Unaudited Financial Results (Standalone and Consolidated) for the quarter and nine months ended December 31, 2023 along with Limited Review Report thereon, is enclosed herewith. GUFIC BIOSCIENCES LTD. - 509079 - Board Meeting Outcome for Meeting Held On Wednesday, February 14, 2024
Pursuant to Regulation 30 (read with Part A of Schedule III) and 33 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('Listing Regulations'), we wish to inform that the Board of Directors of the Company at its meeting held today, i.e. on Wednesday, February 14, 2024, inter-alia, considered the following matters: 1. Approval of Unaudited Financial Results (Standalone and Consolidated) of the Company for the quarter and nine months ended December 31, 2023 2. Increase in Subscribed Share Capital of Gufic UK Limited, Wholly Owned Subsidiary of the Company 3. Formation/ Incorporation of Company under Section 8 of the Companies Act, 2013 in India for undertaking Corporate Social Responsibility initiatives. The meeting of the Board of Directors commenced at 03:30 p.m. and concluded at 5:30 p.m. GUFIC BIOSCIENCES LTD. - 509079 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Pursuant to Regulation 30 read with Part A of Schedule III of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, this is to inform that the Company will host an Earnings Conference Call for Investors/Analysts on Friday, February 16, 2024 at 4:30 p.m. (IST), during which officials of the Company will discuss the business background/prospects and financial performance of the Company and take questions. The details of the Earnings Conference Call are mentioned in the Call Invite which is enclosed herewith. GUFIC BIOSCIENCES LTD. - 509079 - Board Meeting Intimation for Consideration And Approval Of, Inter Alia, Unaudited Financial Results (Standalone And Consolidated) Of The Company For The Quarter And Nine Months Ended December 31, 2023.
GUFIC BIOSCIENCES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/02/2024 ,inter alia, to consider and approve the Unaudited Financial Results (Standalone and Consolidated) of the Company for the quarter and nine months ended December 31, 2023. Further, in continuation to our disclosure on the Closure of Trading Window dated December 28, 2023 and pursuant to the Company's Code of Conduct for Prevention of Insider Trading framed in accordance with the Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015, the trading window in respect of dealing in the Equity Shares of the Company for all the Designated Persons of the Company along with their immediate relatives, shall continue to remain closed until 48 hours post declaration of the said financial results. GUFIC BIOSCIENCES LTD. - 509079 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Pursuant to Regulation 39(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, and as per information received from M/s. Link Intime India Private Limited, Registrar and Share Transfer Agent of the Company on February 6, 2024, the details of loss of share certificates and request for issue of duplicate share certificate as received by the Company is attached herewith. GUFIC BIOSCIENCES LTD. - 509079 - Intimation Of Grant Of Patent Of Addition
The Company has been granted Patent of Addition, the details of the same is attached herewith. GUFIC BIOSCIENCES LTD. - 509079 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Pursuant to Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018, please find enclosed herewith certificate received from M/s. Link Intime India Private Limited, Registrar and Share Transfer Agent (RTA) of the Company for the quarter ended December 31, 2023. GUFIC BIOSCIENCES LTD. - 509079 - Closure of Trading Window
Intimation of Closure of Trading Window is attached herewith.